Browsing Brody School of Medicine by Title
Now showing items 1475-1485 of 1485
-
Waldrum keeps focus community health
(2021-09-29)This is a weekly Q and A newspaper column under the byline of Dr. Kathy Kolasa. Today's column is an interview with Dr. Mike Waldrum, the CEO of Vidant Health and now also the dean of Brody School of Medicine. -
What Constitutes an Extended-Spectrum beta-lactamase?
(East Carolina University, 2002-02) -
What to do when doctors disagree on diet for women with Gestational Diabetes
(2018-05)Medical nutrition therapy is considered the cornerstone of treatment for gestational diabetes mellitus, even though there is no consensus on the best dietary approach to achieve optimal glycemic control and positive maternal ... -
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.
(East Carolina University, 1995-09)OBJECTIVE: This report documents that the gastric bypass operation provides long-term control for obesity and diabetes. SUMMARY BACKGROUND DATA: Obesity and diabetes, both notoriously resistant to medical therapy, continue ... -
Why Does Exercise “Trigger� Adaptive Protective Responses in the Heart?
(2015-05)Numerous epidemiological studies suggest that individuals who exercise have decreased cardiac morbidity and mortality. Pre-clinical studies in animal models also find clear cardioprotective phenotypes in animals that ... -
YC-1 Stimulates the Expression of Gaseous Monoxide-Generating Enzymes in Vascular Smooth Muscle Cells
(East Carolina University, 2009-01)The benzylindazole derivative 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) is an allosteric stimulator of soluble guanylate cyclase (sGC) that sensitizes the enzyme to the gaseous ligands carbon monoxide (CO) and ... -
Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib
(2013-11)Purpose: Yttrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering ... -
Zinc Deficiency and the Cell Cycle: a Scoping Review Protocol
(2020-06-06)This is a protocol for a scoping review regarding zinc deficiency and the cell cycle. The purpose of a protocol is to have an a priori methodology for the scoping review process. The scoping review will allow us to map key ...